Single-Shot Vaccine Shows Complete Protection Against…

Single-Shot Vaccine Shows Complete Protection Against Deadly Andes Virus in Early Study Published: June 2026 | Category: Infectious Diseases, Vaccines, Public Health | TALMedora Editorial Desk A single injection may one day help stop one of the world's most dangerous emerging viruses. Researchers have reported encouraging results from an experimental vaccine that provided complete protection against Andes hantavirus in preclinical testing. The findings raise hopes for a fast-acting vaccine that could help control outbreaks of a virus known for causing severe illness and carrying a high fatality rate. While the vaccine still needs to undergo human clinical trials, scientists believe it could become an important tool for outbreak response and pandemic preparedness. The Andes virus belongs to the hantavirus family, a group of viruses capable of causing severe respiratory disease in humans. Unlike most hantaviruses, which are primarily transmitted through contact with infected rodents, the Andes virus has a unique and worrying characteristic: It can spread directly from one person to another. Transmission can occur through close contact with infected individuals, making the virus more difficult to contain once outbreaks begin. Although infections remain relatively rare, outbreaks can be deadly and require intensive public health interventions. Interest in Andes virus increased following a recent outbreak linked to a cruise ship traveling in South America. Several passengers and crew members became infected, and cases were later traced across multiple countries after travelers returned home. Because symptoms may take weeks to appear, health